| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |